A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma (EXHALE-3)
Clinical trial NCT05813288 · TERMINATED
Trial details
- NCT number
- NCT05813288
- Sponsor
- Areteia Therapeutics
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2023-03-27
- Primary completion
- 2025-12-08
- Enrollment
- 654
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.